Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control

NCT: NCT07056361 · RECRUITING

NCT IDNCT07056361
StatusRECRUITING
Start Date2022-12-16
Completion2030-12-31
SponsorJorge Gonzalez-Martinez (OTHER)
First posted
Last updated

Brief Summary

In this study the investigators aim to enroll patients scheduled to undergo deep brain stimulation (DBS) implantation for movement disorders for intra-operative testing. In addition to standard-of-care surgical procedure to implant deep brain stimulation electrode leads, participants will also be stimulated and recorded from cortical areas by a temporary strip electrode (1X6) in the subdural space. The electrodes will be connected to external stimulators and a series of experiments will be performed to assess effects of the DBS on movement quality and electrophysiology measures. Results of this study will elucidate the biological mechanisms related to deep brain stimulation in modulating motor and speech function in patients with abnormal movement disorders.

Frequently Asked Questions

What is Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control?

Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control is a clinical trial registered under NCT07056361. Current status: RECRUITING.

What is the status of NCT07056361?

The current status of NCT07056361 (Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control) is: RECRUITING.

When did Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control start?

Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control started on 2022-12-16.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.